COVID-19 oxygen crisis: No supply in six private Delhi hospitals, others running low, Manish Sisodia tells Centre
Two of the six hospitals — Saroj Super Specialty Hospital and Shanti Mukund Hospital — have been flagging their shortage since Thursday morning
COVID-19 oxygen crisis: MHA directs states, UTs to not impose restrictions on movement of medical oxygen
The order also said that it has accepted the EG-II's recommendation to prohibit the supply of oxygen for industrial purposes by manufacturers and suppliers from 22 April with the exception of nine specified industries
The drug Pegylated Interferon Alpha 2b is a single-dose regimen is supposed to be less cumbersome and more affordable.
Like anti-malaria drug hydroxychloroquine — so far unproven by clinical trials — ivermectin is widely available and cheap.
Arthritis drug Tocilizumab may improve survival in patients with severe COVID-19, Indian study proposes
Another large study in the UK has found tocilizumab effective in preventing death in COVID-19 patients who suffered from hypoxia and systemic inflammation.
At 50 percent reduction in symptoms, there were no significant difference between the groups who got the usual care, vitamin C, zinc gluconate or both medicines.
The study, backed by £33.6 million in government funding, will work with London's Royal Free Hospital to infect around 90 volunteers between 18 and 30 years.
Eli Lilly's, Regeneron's antibody drugs against COVID-19 raise hopes of preventing infection, hospitalisation
Eli Lilly’s study of 1,035 outpatients recently diagnosed with COVID-19 revealed that only 2 percent needed hospitalisation on its drug.
Experts have said drugs like Lilly’s could serve as a bridge to help manage the virus until vaccines are widely available.
Many COVID-19 vaccines already in circulation are up to 95 percent effective, provided other conditions including mental health are met.
The study authors also said that drugs targeting endothelial activation should be used to control inflammation and coagulopathy associated with COVID-19
Researchers also found about 127 other shared molecules between SARS-CoV-2 and other coronaviruses that were involved in various biological processes ranging from cell to cell communication metabolic processes going on inside the cell and cell growth
African health official blasts 'terrible' vaccine inequality; high-income nations oppose proposal to waive IP rules
A small group of high-income countries and their trading partners, including the EU, US, Brazil, Canada, Japan and the UK Thursday opposed South Africa and India's request to waive some intellectual property rules to allow for faster, easier access to COVID-19 vaccines around the world
UK investigates two adverse reactions to Pfizer jab, says people with history of serious allergic reactions shouldn't get inoculated
Professor Stephen Powis, national medical director for the National Health Service in England, said the condition of the two people who received the vaccine are recovering well
WHO advises against use of Remdesivir to treat COVID-19, says drug has no 'important effect' to reduce deaths
A WHO Guideline Development Group of international experts said there was 'no evidence based on currently available data that the anti-viral drug does improve patient-important outcomes'
As per the study, most adults with moderate to severe COVID-19 have a suppressed immune response against the novel coronavirus rather than life-threatening hyper-inflammation
COVID-19 treatment: Melatonin hormone that regulates sleep-wake cycle may prove effective in managing infection
Clinical registries from Cleveland Clinic also showed that regular use of melatonin was associated with a 30 percent lesser chance of testing positive for COVID-19 even after adjusting for age, smoking history, race, and the presence of comorbidities
The researchers concluded that, to their knowledge, the llama nanobodies they isolated and used to eliminate their SARS-CoV-2 samples are the most potent neutraliser to date
By December, Gilead expects to produce enough of the drug to treat 2 million patients, and is exploring an inhaled form of it for outpatients.
Scientists stated that aspirin can reduce the production of immune cells in patients with pre-existing cardiovascular disease, thus helping in reducing the incidence of a cytokine storm